Biosimilars: US FDA Considering ‘Guardrails’ To Prevent Misinformation

 
• By Sue Sutter
  
Guardrail_Road
Communications about biosimilars may require some guardrails. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics